We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




HPV Test Better Than Pap Test

By HospiMedica staff writers
Posted on 30 Jun 2006
Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions in the cervix.

Previous studies have shown that searching for a precancerous cervical lesion called cervical intraepithelial neoplasma using an HPV test is more sensitive but has more false-positives than conventional Pap smears, where doctors look for abnormal cells on a slide. More...
Liquid-based cytology is a newer Pap technology where the doctors first immerse the Pap sample in a solution before looking at the cells. A new study comparing the ability of these tests to discover precancerous cervical lesions was reported in the June 7, 2006, issue of the Journal of the National Cancer Institute.

Guglielmo Ronco, M.D., Ph.D., of the Centro per la Prevenzione Oncologica Piemonte (CPO, Turin, Italy), and colleagues conducted a randomized controlled trial that screened over 33,000 women for cervical cancer. Half of the women were tested with Pap smears and the other half with HPV tests and liquid-based cytology. Women who had a positive result with any test were further examined by a technique called colposcopy, where a magnifying instrument is inserted to obtain a detailed view of the cervix.

The results showed that HPV testing alone was more sensitive than Pap smears among women 35-60 years old. Adding liquid-based cytology improved sensitivity only marginally but increased false-positives.



Related Links:
CPO

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.